The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Caris Life Sciences announced positive results for its multi-cancer detection study. On March 31, the company finalized the Achieve 1 study, validating the accuracy of its Caris Detect early detection test. The results demonstrated the superiority of Whole Genome Sequencing (WGS) over methylation-based approaches in sensitivity and specificity. This milestone is a key step toward the future launch of the Caris Detect™ test.